Cambridge Oncometrix (AgeTech UK) TeleHealth
Cambridge Oncometrix test will aid identification of men suspected of prostate cancer who can safely forgo prostate biopsy. We aim to reduce the number of unnecessary prostate biopsies by 50%.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership